To compare the cardio- and cerebrovascular outcomes and survival rates of surgical and nonsurgical interventions for patients with obstructive sleep apnea (OSA) based on a national population-based database.
Study Design
Retrospective cohort study.
Setting
Taiwan National Health Insurance Research Database.
Methods
We analyzed all cases of OSA among adults (age >20 years and confirmed with ICD-9-CM) from January 2001 to December 2013. We compared the patients with OSA who received upper airway surgery with age-, sex-, and comorbidity index–matched controls with continuous positive airway pressure (CPAP) treatment. The risk of myocardial infarction (MI) or stroke after treatment of OSA-related surgery versus CPAP was investigated.
Results
During follow-up, 112 and 92 incident cases of MI occurred in the OSA surgery and CPAP treatment groups, respectively (rates of 327 and 298 per 100,000 person-years). Furthermore, 50 and 39 cases were newly diagnosed with stroke in the OSA surgery and CPAP treatment groups (rates of 144 and 125 per 100,000 person-years). Cox proportional hazard regressions showed that the OSA treatment groups (OSA surgery vs CPAP) were not significantly related to MI (hazard ratio, 1.03 [95% CI, 0.781-1.359]; P = .833) and stroke (hazard ratio, 1.12 [95% CI, 0.736-1.706]; P = .596) at follow-up, after adjustment for sex, age at index date, days from diagnosis to treatment, and comorbidities.
Conclusion
Our study demonstrated that there was no difference of cardio- and cerebrovascular results between CPAP and surgery for patients with OSA in a 13-year follow-up.
SullivanCEIssaFG. Pathophysiological mechanisms in obstructive sleep apnea. Sleep. 1980;3(3-4):235-246.
2.
GuilleminaultCTilkianAGDementWC. Sleep and respiration in the syndrome “apnea during sleep” in the child. Article in French. Electroencephalogr Clin Neurophysiol. 1976;41(4):367-378.
3.
FusettiMFiorettiABValentiMMaseduFLaurielloMPagliarellaM. Cardiovascular and metabolic comorbidities in patients with obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Ital. 2012;32(5):320-325.
4.
JennumPIbsenRKjellbergJ. Social consequences of sleep disordered breathing on patients and their partners: a controlled national study. Eur Respir J. 2014;43(1):134-144.
5.
TsaiMSLeeLATsaiYT. et alSleep apnea and risk of vertigo: a nationwide population-based cohort study. Laryngoscope. 2018;128(3):763-768.
MarinJMCarrizoSJVicenteEAgustiAG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365(9464):1046-1053.
8.
Garcia-RioFAlonso-FernandezAArmadaE. et alCPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol. 2013;168(2):1328-1335.
9.
DimsdaleJELoredoJSProfantJ. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension. 2000;35(1, pt 1):144-147.
10.
BarnesMHoustonDWorsnopCJ. et alA randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165(6):773-780.
11.
LinHCFriedmanMChangHWGurpinarB. The efficacy of multilevel surgery in adults with obstructive sleep apnea/hypopnea syndrome. Laryngoscope. 2008;118(5): 902-908.
12.
LinHCFriedmanMChangHWBonzelaarLSalapatasAMLinMCHuangKT. Minimally invasive, single-stage, multilevel surgery for obstructive sleep apnea in Asian patients. JAMA Otolaryngol Head Neck Surg. 2017;143(2):147-154.
13.
LinHCFriedmanMChangHWSuMCWilsonM. Z-palatopharyngoplasty plus radiofrequency tongue base reduction for moderate/severe obstructive sleep apnea/hypopnea syndrome. Acta Otolaryngol. 2010;130(9):1070-1076.
14.
LinHCFriedmanMChangHWYalamanchaliS. Z-palatopharyngoplasty combined with endoscopic coblator open tongue base resection for severe obstructive sleep apnea/hypopnea syndrome. Otolaryngol Head Neck Surg. 2014;150(6):1078-1085.
15.
HalleTROhMSCollopNAQuyyumiAABliwiseDLDedhiaRC. Surgical treatment of OSA on cardiovascular outcomes: a systematic review. Chest. 2017;152(6):1214-1229.
IpMSTseHFLamBTsangKWLamWK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169(3):348-353.
18.
MarshallNSWongKKLiuPYCullenSRKnuimanMWGrunsteinRR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep. 2008;31(8):1079-1085.
19.
ArztMHetzeneckerASteinerSBuchnerS. Sleep-disordered breathing and coronary artery disease. Can J Cardiol. 2015;31(7):909-917.
20.
MunozRDuran-CantollaJMartinez-VilaE. et alSevere sleep apnea and risk of ischemic stroke in the elderly. Stroke. 2006;37(9):2317-2321.
21.
MooeTRabbenTWiklundUFranklinKAErikssonP. Sleep-disordered breathing in men with coronary artery disease. Chest. 1996;109(3):659-663.
22.
PekerYCarlsonJHednerJ. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 2006;28(3):596-602.
23.
MontesiSBEdwardsBAMalhotraABakkerJP. The effect of continuous positive airway pressure treatment on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Clin Sleep Med. 2012;8(5):587-596.
24.
JenkinsonCDaviesRJMullinsRStradlingJR. Long-term benefits in self-reported health status of nasal continuous positive airway pressure therapy for obstructive sleep apnoea. QJM. 2001;94(2):95-99.
25.
AbuzaidASAl AshryHSElbadawiA. et alMeta-analysis of cardiovascular outcomes with continuous positive airway pressure therapy in patients with obstructive sleep apnea. Am J Cardiol. 2017;120(4):693-699.
26.
McEvoyRDAnticNAHeeleyE. et alCPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375(10):919-931.
27.
DicksonRIBlokmanisA. Treatment of obstructive sleep apnea by uvulopalatopharyngoplasty. Laryngoscope. 1987;97(9):1054-1059.
28.
JiangGFSunWLiNSunYZhangNK. Treatment effect of uvulopalatopharyngoplasty on autonomic nervous activity during sleep in patients with obstructive sleep apnea syndrome. Chin Med J (Engl). 2004;117(5):761-763.
29.
PengYZhangLHuD. et alReduction of internal carotid artery intima-media thickness in patients with moderate-to-severe obstructive sleep apnea syndrome after nasal surgery and uvulopalatopharyngoplasty. Acta Otolaryngol. 2016;136(5):514-521.
30.
LinHCLeeCYFriedmanM. et alEffects of minimally invasive surgery for patients with OSA on quality of life. Ann Otol Rhinol Laryngol. 2018;127(2):118-123.
31.
LaiCCLinPWLinHC. et alEffects of upper airway surgery on daytime sleepiness in nonobese patients with obstructive sleep apnea/hypopnea syndrome. Ann Otol Rhinol Laryngol. 2018;127(12):912-918.
32.
TsaiMHLinPWLinHC. et alAlternations of blood pressure before and after OSA surgery. Otolaryngol Head Neck Surg. 2020;163(4):843-848.
33.
ChinCHLinPWLinHCFriedmanMLinMC. Effects of OSA surgery on leptin and metabolic profiles. Otolaryngol Head Neck Surg. 2019;161(6):1048-1055.
34.
LinPWLinHCFriedmanM. et alEffects of OSA surgery on ophthalmological microstructures. Ann Otol Rhinol Laryngol. 2019;128(10):938-948.
35.
HuangCCLinHCLaiYR. et alLong-term effects of surgical treatment on baroreflex function in patients with obstructive sleep apnea: an 18-month follow-up. Sleep Med. 2019;60:152-158.
36.
LinWCHuangCCChenHL. et alLongitudinal brain structural alterations and systemic inflammation in obstructive sleep apnea before and after surgical treatment. Transl Med. 2016;14(1):139.
37.
HalleTROhMSCollopNA. et alSurgical treatment of OSA on cardiovascular outcomes: a systematic review. Chest. 2017;152(6):1214-1229.
38.
WeaverEMMaynardCYuehB. Survival of veterans with sleep apnea: continuous positive airway pressure versus surgery. Otolaryngol Head Neck Surg. 2004;130(6):659-665.
39.
RotenbergBWViciniCPangEB. et alReconsidering first-line treatment for obstructive sleep apnea: a systematic review of the literature. J Otolaryngol Head Neck Surg. 2016;45:23.
